Aharon Aharon - 13 May 2026 Form 4 Insider Report for Innoviz Technologies Ltd. (INVZ)

Reporting relationship: Director
Issuer ticker: INVZ
Reported as of: 13 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 May 2026, 06:01:28 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Dafna Raz - Attorney-in-Fact

Key filing fact

Aharon Aharon filed Form 4 for Innoviz Technologies Ltd. (INVZ) on 15 May 2026.

Key facts

This page summarizes Aharon Aharon's Form 4 filing for Innoviz Technologies Ltd. (INVZ).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 May 2026, 06:01.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001966840 Primary reporting owner

Aharon Aharon

Relationship: Director
Address: C/O INNOVIZ TECHNOLOGIES LTD., 5 URI ARIAV STREET, BUILDING C, ROSH HA'AIN, ISRAEL
Signature: /s/ Dafna Raz - Attorney-in-Fact
Signature date: 14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INVZ transaction

Ordinary Shares

Award

Transaction value
Shares: +110,668
Change %: +47%
Price: $0.000000^*
Shares after: 344,997
Date: 13 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 110,668 Restricted Share Units (RSUs) granted on May 13, 2026, which shall fully vest on April 5, 2027, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

Footnote F2

Includes 234,329 ordinary shares.